4
1
mg/dL
6
mg/dL
11
mg/dL
1
4
1
mg/dL
6
mg/dL
11
mg/dL
1
The Newborn Bilirubin Calculator is an essential clinical tool used to assess the risk of neonatal hyperbilirubinemia (newborn jaundice) and determine whether phototherapy or exchange transfusion is needed. Jaundice affects approximately 60% of full-term and 80% of preterm newborns during the first week of life, making bilirubin assessment one of the most common evaluations in neonatal care.
Bilirubin is a yellow pigment produced from the normal breakdown of red blood cells. In newborns, the immature liver may not conjugate and excrete bilirubin efficiently, leading to accumulation in the blood and tissues. While mild jaundice is physiological and harmless, severely elevated bilirubin levels can cross the blood-brain barrier and cause acute bilirubin encephalopathy or permanent kernicterus, a devastating condition resulting in cerebral palsy, hearing loss, and intellectual disability.
This calculator uses the hour-specific bilirubin nomogram developed by Bhutani et al. and endorsed by the American Academy of Pediatrics (AAP) in their 2004 and 2022 clinical practice guidelines. The nomogram plots total serum bilirubin (TSB) against the newborn's age in hours, classifying the result into risk zones: low, low-intermediate, high-intermediate, and high.
Treatment thresholds depend on three key factors: the TSB level, the newborn's age in hours, and the presence of risk factors. Risk factors include prematurity (35-37 weeks gestational age), isoimmune hemolytic disease (ABO or Rh incompatibility), G6PD deficiency, significant lethargy, temperature instability, sepsis, acidosis, and albumin levels below 3.0 g/dL. The calculator provides individualized phototherapy and exchange transfusion thresholds based on these parameters.
Early identification of newborns at risk for severe hyperbilirubinemia is critical for timely intervention. The AAP recommends universal screening with either TSB or transcutaneous bilirubin (TcB) measurement before hospital discharge. This calculator aids clinicians in interpreting results and making evidence-based treatment decisions to prevent bilirubin-related brain injury.
The calculator implements the AAP hour-specific nomogram for phototherapy thresholds:
Three threshold curves are defined based on risk category:
Between time points, the threshold is linearly interpolated. The exchange transfusion threshold is approximately 5 mg/dL above the phototherapy threshold. The risk zone is assigned based on where the TSB falls relative to these thresholds: Zone 1 (low), Zone 2 (low-intermediate), Zone 3 (high-intermediate, at or above phototherapy), Zone 4 (high, at or above exchange).
A Risk Zone of 1 indicates low risk — routine follow-up is appropriate. Zone 2 suggests low-intermediate risk — recheck TSB in 12-24 hours. Zone 3 means the TSB is at or above the phototherapy threshold — initiate phototherapy and monitor closely. Zone 4 is critical — the TSB approaches or exceeds the exchange transfusion threshold, requiring urgent intervention. If phototherapy is recommended, the 'Above Phototherapy Threshold' value indicates how far above the treatment line the baby's bilirubin is. Always correlate with clinical assessment and direct/conjugated bilirubin to rule out pathological causes.
Inputs
Results
TSB of 12 at 48 hours in a low-risk infant is below the phototherapy threshold (15). Low-intermediate zone — recheck in 12-24 hours.
Inputs
Results
TSB of 13 at 36 hours in a high-risk preterm exceeds the phototherapy threshold (9.5). Phototherapy should be initiated promptly.
Neonatal jaundice is the yellowish discoloration of a newborn's skin and eyes caused by elevated bilirubin levels. It occurs because newborns produce more bilirubin (from rapid red blood cell turnover) and have immature liver enzymes that cannot conjugate it efficiently.
Normal bilirubin levels vary by age in hours. At 24 hours, TSB below 6 mg/dL is generally low-risk. At 48 hours, below 9 mg/dL is low-risk. Peak physiological jaundice typically occurs at 3-5 days with levels of 5-12 mg/dL in term infants.
Phototherapy is recommended when TSB exceeds the hour-specific threshold for the infant's risk category. For a low-risk term infant at 48 hours, this is approximately 15 mg/dL. For high-risk preterm infants, thresholds are significantly lower.
Kernicterus is a form of permanent brain damage caused by severe unconjugated hyperbilirubinemia. Bilirubin crosses the blood-brain barrier and deposits in the basal ganglia, causing athetoid cerebral palsy, sensorineural hearing loss, upward gaze palsy, and dental enamel dysplasia. It is preventable with proper monitoring.
Major risk factors include prematurity (35-37 weeks), isoimmune hemolytic disease (Rh or ABO incompatibility), G6PD deficiency, East Asian ethnicity, exclusive breastfeeding with weight loss, cephalohematoma, prior sibling with jaundice requiring treatment, and visible jaundice in the first 24 hours.
Phototherapy uses blue-green light (wavelength 430-490 nm) to convert unconjugated bilirubin in the skin into water-soluble photo-isomers (lumirubin) that can be excreted in bile and urine without liver conjugation. Intensive phototherapy can reduce TSB by 1-2 mg/dL within 4-6 hours.
Exchange transfusion is an emergent procedure where the infant's blood is incrementally removed and replaced with donor blood. It rapidly lowers bilirubin and removes antibody-coated red blood cells. It is reserved for TSB levels approaching neurotoxic thresholds or when intensive phototherapy fails.
Breastfeeding should generally NOT be stopped. The AAP recommends continuing breastfeeding with increased frequency (8-12 times/day) to promote bilirubin excretion through stooling. Only in rare cases of severe breastmilk jaundice lasting beyond 2 weeks may temporary interruption be considered.
The Bhutani nomogram is an hour-specific bilirubin chart that plots TSB against age in hours, dividing results into risk zones. Developed by Dr. Vinod Bhutani and colleagues in 1999, it is the standard tool endorsed by the AAP for predicting which newborns are at risk for severe hyperbilirubinemia.
Rechecking depends on the risk zone and age. Infants in the high-intermediate zone should be rechecked in 6-12 hours. Low-intermediate zone infants can be rechecked in 12-24 hours. All newborns should have follow-up within 48 hours of discharge, with earlier follow-up for those discharged before 48 hours of age.
Roboculator Team
The Roboculator Team explains calculations, planning tools, and practical formulas in clear language for real-life situations.
How helpful was this calculator?
Be the first to rate!
